Evaluation of current therapeutic strategies in Behçet's disease

Clin Rheumatol. 2011 Feb;30(2):157-63. doi: 10.1007/s10067-010-1566-4. Epub 2010 Sep 15.


Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of the inflammatory process, using immunomodulating and immunosuppressive agents. In selected cases, invasive procedures may be required.

Publication types

  • Review

MeSH terms

  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / physiopathology
  • Humans
  • Immunomodulation
  • Immunosuppressive Agents / therapeutic use*


  • Immunosuppressive Agents